Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Vasculitis
•
Systemic lupus erythematosus
•
Cyclophosphamide
•
General Rheumatology
•
Infectious Disease
•
Tuberculosis
•
Latent Tuberculosis
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
Related Questions
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
How would you approach management of a patient with mixed cryoglobulinemic vasculitis with predominant skin involvement and no major organ involvement?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
How do you approach the management of digital ischemia in a critically ill patient with infection, but no evidence of active rheumatologic disease?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How often do you see bony erosions in patients with Lyme arthritis?
How would you approach management of nodular scleritis in the setting of suspected GCA?